BlackRock’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $95.6K | Sell |
|
|||||
|
2023
Q4 | $131K | Sell |
|
|||||
|
2023
Q3 | $270K | Sell |
|
|||||
|
2023
Q2 | $660K | Sell |
|
|||||
|
2023
Q1 | $2.52M | Sell |
|
|||||
|
2022
Q4 | $3.37M | Buy |
|
|||||
|
2022
Q3 | $20.6M | Sell |
|
|||||
|
2022
Q2 | $17.4M | Buy |
|
|||||
|
2022
Q1 | $20.3M | Sell |
|
|||||
|
2021
Q4 | $12.8M | Sell |
|
|||||
|
2021
Q3 | $16.5M | Sell |
|
|||||
|
2021
Q2 | $21.1M | Sell |
|
|||||
|
2021
Q1 | $22.2M | Buy |
|
|||||
|
2020
Q4 | $29.2M | Buy |
|
|||||
|
2020
Q3 | $18.3M | Buy |
|
|||||
|
2020
Q2 | $18.9M | Buy |
|
|||||
|
2020
Q1 | $12.7M | Sell |
|
|||||
|
2019
Q4 | $28.2M | Buy |
|
|||||
|
2019
Q3 | $18.3M | Buy |
|
|||||
|
2019
Q2 | $18.3M | Buy |
|
|||||
|
2019
Q1 | $6.33M | Sell |
|
|||||
|
2018
Q4 | $4.76M | Buy |
|
|||||
|
2018
Q3 | $2.69M | Buy |
|
|||||
|
2018
Q2 | $2.67M | Buy |
|
|||||
|
2018
Q1 | $797K | Buy |
|
|||||
|
2017
Q4 | $402K | Buy |
|
|||||
|
2017
Q3 | $310K | Sell |
|
|||||
|
2017
Q2 | $226K | Sell |
|
|||||
|
2017
Q1 | $2.13M | Buy |
|
|||||
|
2016
Q4 | $2K | Hold |
|
|||||
|
2016
Q3 | $2K | Hold |
|
|||||
|
2016
Q2 | $3K | Buy |
|